FDA Enforcement Class I Terminated

SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and drug delivery system intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures. Intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures.

Recall: Z-2374-2015 · Reported September 2, 2015

Enforcement

Recall Number
Z-2374-2015
Event ID
71551
Classification
Class I
Status
Terminated
Product Type
Devices
Firm
Ethicon Endo-Surgery Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
September 2, 2015
Initiation Date
May 13, 2015
Classification Date
August 26, 2015
Termination Date
May 2, 2016
Address
4545 Creek Rd, N/A, Blue Ash, OH, 45242-2803, United States

Description

SEDASYS Computer-Assisted Personalized Sedation System, SEDPRU01. An integrated physiological monitoring and drug delivery system intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures. Intended to provide physician-led teams with a means of administering 1% propofol (10 mg/mL) injectable emulsion to sedate patients > 18 (ASA I-II) undergoing esophagogastroduodenoscopy (EGD) and colonoscopy procedures.

Reason

Ethicon has found that disinfecting methods not specified in the Instructions For Use (IFU) have led to the degradation of the plastic material of the SEDASYS System Control Unit.

Code Info

Model #SEDPRU01

Distribution

Nationwide Distribution including OH, RI, TX & WA.

Quantity

14 units